west virginia semaglutide intestinal paralysis class action ALL FMGs ASSOCIATION - AFA | Why is Ozempic getting sued? Ozempic, a glucagon-like peptide-1 (GLP-1) receptor agonist originally designed for diabetes, shot to global semaglutide intestinal paralysis class action
Description
Factors such as side effects, high out-of-pocket costs, injection fatigue and stigma around obesity treatment drive troves of patients some studies estimate roughly half or more to stop GLP-1s within a year and risk regaining the weight they lost
Improve your experience
For some members, long-term use is the right answer
A doctor explains what to do when you miss, run out or cant refill your medication
Soluble in sterile water or bacteriostatic water
states.
